Ningetinib tosylate blocks the activity of platelet-derived growth factor receptors (PDGFR), which play a crucial role in cell growth, angiogenesis, and tissue. It targets VEGFR2.
Molecular Weight
728.79
Molecular Formula
C38H37FN4O8S
Targets
VEGFR2: 1.9 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Ningetinib tosylate is used as a PDGFR inhibitor in research on cancer treatment modalities involving growth factor signaling.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
